search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Pulsatile II study.


- candidate number9759
- NTR NumberNTR2940
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR16-jun-2011
- Secondary IDsANES2010/070 VUMC Department of anesthesiology
- Public TitlePulsatile II study.
- Scientific TitlePreservation of microcirculatory perfusion after pulsatile cardiopulmonary bypass: The role of prothrombogenic processes and the endothelium.
- ACRONYMPulsatile II
- hypothesisPulsatile flow during cardiopulmonary bypass (CPB) results in preservation of microcirculatory function in the early postoperative period as compared to non-pulsatile CPB.
- Healt Condition(s) or Problem(s) studiedCoronary Artery Bypass Grafting (CABG), Pulsatile cardiopulmonary bypass, Microcirculatory perfusion, Endothelial function, Platelet aggregation, Fibrinolysis
- Inclusion criteria1. Patients undergoing coronary artery bypass surgery (CABG);
2. Age 40-85 years;
3. Informed consent.
- Exclusion criteria1. Re-operations and emergency operations;
2. Patients with insulin-dependent diabetes mellitus;
3. Patients with a body mass index (BMI) > 35 kg/m2;
4. Patients with anemia (Hb < 5.5 mmol/l).
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingSingle
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 20-jun-2011
- planned closingdate20-jun-2012
- Target number of participants48
- InterventionsPulsatile cardiopulmonary bypass vs. non-pulsatile cardiopulmonary bypass.
- Primary outcomeChange in microcirculatory perfusion during surgery, sublingual erythrocyte velocity, capillary diameter and capillary density.
- Secondary outcome1. Platelet aggregation;
2. Fibrin formation/degradation;
3. Red blood cell deformability;
4. Endothelial barrier function;
5. Endothelial biomarker expression.
- TimepointsMeasurements take place during the day of the operation and end within 4 hours after the operation.
- Trial web sitewww.vumc.nl/afdelingen/anesthesiologie
- statusstopped: trial finished
- CONTACT FOR PUBLIC QUERIESDr. Christa Boer
- CONTACT for SCIENTIFIC QUERIESDr. Christa Boer
- Sponsor/Initiator VU University Medical Center
- Funding
(Source(s) of Monetary or Material Support)
European Association for Cardiothoracic Anesthesiologists, Institute for Cardiovascular Research
- PublicationsN/A
- Brief summaryRationale:
Non-pulsatile cardiopulmonary bypass (CPB) during cardiac surgery is associated with postoperative disturbances in microcirculatory perfusion, which are prevented by reinstatement of pulsatile flow. Moreover, impaired microcirculatory perfusion after non-pulsatile flow correlates with the presence of prothrombogenic markers. The question arises whether prothrombogenic alterations are indeed related to disturbances in microcirculatory perfusion, and how this relation is affected by non-pulsatile and pulsatile CPB. Furthermore, it is unknown whether the relation of a prothrombogenic profile with microcirculatory perfusion involves distinct alterations in endothelial function.

Objectives:
We aim to investigate whether pulsatile flow in patients subjected to CPB preserves postoperative microcirculatory perfusion by prevention of a prothrombogenic profile and endothelial activation as are both present under non-pulsatile flow conditions.

Study design:
Single-center prospective, randomized study in the VUmc.

Study population:
Patients undergoing elective coronary bypass graft surgery (CABG; n = 48). Patients will be randomly assigned into two study groups:
1. Non-pulsatile flow: Continuous flow during CPB;
2. Pulsatile flow: Pulsatile flow during CPB.

Intervention:
The intervention consists of the application of one type of cardiopulmonary bypass (conventional or pulsatile CPB). All interventions are part of standard clinical care.

Main study parameters/endpoints:
Change in microcirculatory perfusion, sublingual erythrocyte velocity, capillary diameter and capillary density.
- Main changes (audit trail)
- RECORD16-jun-2011 - 7-jan-2016


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl